Cancer antigens: immune recognition of self and altered self.
Open Access
- 1 July 1994
- journal article
- editorial
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 180 (1), 1-4
- https://doi.org/10.1084/jem.180.1.1
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor.Proceedings of the National Academy of Sciences, 1994
- The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.The Journal of Experimental Medicine, 1993
- The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot.1992
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991
- Structure of the gene of tum- transplantation antigen P198: a point mutation generates a new antigenic peptide.The Journal of Experimental Medicine, 1990
- The melanoma antigen gp75 is the human homologue of the mouse b (brown) locus gene product.The Journal of Experimental Medicine, 1990
- Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells.Proceedings of the National Academy of Sciences, 1989
- Class 1 (unique) tumor antigens of human melanoma. Identification of a 90,000 dalton cell surface glycoprotein by autologous antibody.The Journal of Experimental Medicine, 1984
- Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets.The Journal of Experimental Medicine, 1982
- Teratocarcinoma cell variants rejected by syngeneic mice: protection of mice immunized with these variants against other variants and against the original malignant cell line.Proceedings of the National Academy of Sciences, 1978